Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mifepristone and Misoprostol Versus Misoprostol Alone for Uterine Evacuation After Early Pregnancy Failure: a Randomized Double Blind Placebo-controlled Comparison (Triple M Trial)

NCT03212352 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT03212352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03212352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mifepristone and Misoprostol Versus Misoprostol Alone for Uterine Evacuation After Early Pregnancy Failure: a Randomized Double Blind Placebo-controlled Comparison (Triple M Trial)
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
June 27, 2018
Completion date
March 16, 2020
Enrollment
342 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

early pregnancy failure